CHI Special Investigation · Founder-Level

Mark CubanThe Price-Setter Test

When Mark Cuban sets the price, the customer usually wins.

Cost Plus Drugs was not a one-off. But the pattern stops where Cuban stops controlling the price the customer sees.

Broad founder thesis Weakly supports

That Cuban demonstrates a repeatable operating philosophy of attacking opaque, extractive or customer-hostile models across the businesses he owns, controls, invests in or influences.

Narrower price-setter thesis Supports

That where Cuban directly sets the consumer price, he makes it legible and prices it to the customer's alternative — and that where he sits upstream of it, that alignment becomes inconsistent or disappears.

Confidence Medium

The strongest positive and negative exhibits are well sourced. Several “no historical analogue” conclusions are search-limited, and founder attribution changes materially across control roles.

Third finding Low-touch digital support: supports as a friction pattern A recurring architecture in Cuban-built digital products — forms, email, limited frontline human visibility, founder accessibility operating outside the formal service channel. It is a friction pattern, not a customer-alignment pattern.

23 yrsDallas Mavericks under Cuban's control, Jan 2000 – 27 Dec 2023

18 yrsHDNet as a subscriber-invisible carriage-fee network, 2001–2019

0Strong pre-2022 operating analogues for any Cost Plus inverse mechanism

10Cost Plus inverse mechanisms tested against the whole prior record

Two verdicts, not one. They answer two different propositions, and the narrower one is the better evidenced. A reader who takes SUPPORTS on the price-setter thesis as SUPPORTS on the broad founder thesis has read this page backwards.

● 22 minute read · Research cutoff 6 September 2026

Why this investigation exists

A company passed. So we investigated its founder.

CHI more often documents hostility than its absence. Cost Plus Drugs was the rare positive control — and a positive control raises a question about provenance.

On 5 September 2026 CHI's assessment of the Mark Cuban Cost Plus Drug Company returned supports. The company had genuinely engineered rent extraction out of the price of a generic drug. On a public product page, before any account exists and before a prescriber is involved, the customer sees the acquisition cost, a fixed 15 per cent markup, a $5.00 pharmacy labour fee and a $5.25 standard shipping charge. An audit sample of 60 product pages reconciled to the cent on all 60. No coupon, membership, formulary, rebate, spread or clawback sat between the displayed number and the charged one.

That finding was unusual enough to raise a question the company page could not answer. A mechanism that removes rent from a price can be an accident of one product team, a response to one regulatory moment, or the expression of something its founder always does. Only the third reading would justify CHI treating the founder rather than the company as the unit of analysis — and the third reading is the one Cuban's own promotional voice invites.

So this investigation asked a single question and refused to presume its answer: was Cost Plus an isolated consumer-aligned experiment, or the clearest expression of a business instinct Cuban had demonstrated elsewhere? It tested that across his business history — MicroSolutions, Broadcast.com, the Dallas Mavericks, HDNet/AXS TV, 2929 Entertainment, Landmark, Magnolia, Sharesleuth, Cyber Dust, Fireside, the Shark Tank portfolio, and the Cost Plus family — classifying every entity by what Cuban actually controlled and refusing to credit accessibility, disruption, low price or rhetoric unless a structural mechanism aligned his gain with the customer's.

This page does not re-litigate the Cost Plus assessment. It establishes only what is needed to explain why a founder-level investigation was necessary, and then reports what the founder-level record shows.

What CHI already found against Cost Plus. The same assessment recorded material contradictions: a savings comparator anchored to a frozen third-party average the FAQ itself concedes “may not reflect current market prices”; mandatory arbitration with no opt-out; an auto-refill term that contradicts the FAQ's seven-day promise; and a support surface that routes ordinary patients through forms. Nothing on this page is a character reference for the company. Read the full company assessment →

The central finding

The boundary is the finding.

This investigation is not about whether Mark Cuban is on the customer's side. It is about a line that runs through his record, and about which side of it a given business sits on. The line is not industry, not decade, not personality. It is the answer to one question: did Cuban set the price the customer paid?

When Cuban

Sets the consumer price

He makes it legible and prices it to the customer's realistic alternative rather than to the revenue-maximising point — and, since 2022, he writes that into a mechanism rather than a management choice.

Dallas Mavericks Owner, 2000–2023A published cheap-seat floor: the 2006–07 upper-bowl cut and $2 ticket, the 2010 $2 / $5 / $10 tiers, a 2014 process built on filling the arena rather than maximising per-seat revenue.
Cost Plus Drugs Co-founder, 2022–Cost, markup, labour and shipping itemised on a public page before identity. One price. No coupon layer.
Team Cuban Card Co-founder, 2023–The same stack republished with a different fee schedule: drug cost, 15 per cent markup, $12.00, $1.00.
Cost Plus Wellness Sponsor, 2024–62 employer–provider contracts published in full at a zero platform fee, as of 6 September 2026.

Result: alignment that is real, dated and repeated — and, after 2022, structural.

When Cuban

Sits upstream of it

As supplier, channel participant, advocate or endorser, he is willing to operate inside — and to defend — the same kind of opaque pricing surface he criticises when someone else owns it.

HDNet / AXS TV Primary owner, 2001–2019Eighteen years inside a per-subscriber carriage-fee model the viewer never saw. He defended the retail bundle to the FCC, sued a distributor to stay out of an opt-in tier, and never disclosed the rate.
Sharesleuth Founder and sole funder, 2006–A free investigative site financed by the owner's short positions in its subjects, with disclosure of the conflict — its existence, not its size, entry or exit — offered as the answer to it.
Voyager promotion Endorser, Oct 2021A Cuban-controlled fan channel and a personal endorsement carried a third party's “commission-free” consumer proposition whose economics were not legible — twelve weeks before Cost Plus launched.
Net-neutrality advocacy Interested party, 2006–2015Consistent opposition to neutral-carriage rules while a fee recipient inside the pipe.

Result: the alignment becomes inconsistent, or it disappears entirely.

Same founder. Same decades. The variable is not conviction — it is his position in the transaction.

What this page does not say. Not that Cuban has always been on the consumer's side. Not that Cost Plus proves he has followed one philosophy for decades. Not that he consistently fights middlemen. None of those is supported by the record. The finding is narrower and more useful: the mechanism changes with his role in the transaction.

The record on the aligned side

Six dated instances, twenty years apart.

These are the exhibits that carry the narrower thesis to SUPPORTS. Each is primary where it matters, each falls inside Cuban's control window, and each is a case in which he personally set what a consumer paid.

2006–07 · Dallas Mavericks

The upper-bowl cut and the $2 ticket

Writing on 11 December 2006, mid-way through a title-contending season with a running sellout streak, Cuban recorded that “we lowered the price of all tickets in our upper bowl and created a TWO DOLLAR ($2) ticket for 10 of our games”, with the stated theory that “lowering ticket prices is the most powerful, least expensive marketing we can do”. A post from 7 November 2006 corroborates it from the seats themselves.

Six months earlier he had declined to auction NBA Finals tickets: “If we were greedy, the Mavs would just put the tickets up for auction and take in the full value the market assigns to them.” An available rent, named as the greedy option, declined at the moment of maximum leverage.

Cuban's rolePrincipal owner. He set the schedule directly.

Structural?A price schedule, not a mechanism. Real, contemporaneous, and reversible by whoever owned the team next.

Price-setterManagerial practicePrimary source

2010 · Dallas Mavericks

A published low-price floor

The floor was not a one-season promotion. In September 2010 Cuban listed it publicly: “$2 for at least 10 games during the year. We have $5 singles for every game. We have 10 dollars seats for every game… We have more than 4k tickets priced under $20 for every game” — with best-available seats sold at the box office shortly before tip-off.

What makes this evidence rather than marketing is that the cheapest inventory is named, dated and quantified, and that it recurs: the floor is attested at dated points in 2006, 2010 and again in 2015. It is a floor, not a formula — the construction of the price was never shown to the fan.

Cuban's rolePrincipal owner. Price-setter on primary inventory.

Structural?Published and repeatable while he was in charge; never contractual.

Price-setterPublished floor

Feb 2014 · Dallas Mavericks

Price to fill, not to maximise

On 23 February 2014 Cuban described a full-time analyst continuously monitoring online pricing, and stated the rule: “It is far more important to know the price points that will enable you to fill the arena than to know the price points that will max out your total revenue.” The process, he wrote, “has resulted in us changing pricing for 7k season tickets for this coming year.”

The direction of that repricing is not stated in the post, and CHI does not infer it. What is not inferential is the rule itself: the reference point is the fan's outside option — the secondary market — rather than the revenue-maximising point. The same market-monitoring function was used by the team's later owners in the opposite direction, which is exactly why the tool cannot be read as a direction.

Cuban's rolePrincipal owner. He set the pricing process.

Structural?A pricing process, and direction-neutral as a tool. Supports as process only.

Price-setterProcess, not outcome

19 Jan 2022 · Cost Plus Drugs

Where instinct becomes architecture

This is the point at which a management preference becomes a mechanism. A public product page shows the acquisition cost, a fixed 15 per cent markup, $5.00 pharmacy labour and $5.25 standard shipping — visible before an account exists and before a prescriber is involved. An audit sample of 60 pages reconciled to the cent on all 60.

Itemised margin disclosure — the company's own take is displayed, not just the price.
Price before identity — no login, no insurance card, no eligibility check to see the number.
Single-price logic — no coupon tier, no membership, no negotiated exception.
Opt-in recurrence and zero-cost exit — no membership fee, self-service deletion.

The difference from the Mavericks is not sincerity. It is that this version is written into the product surface and is mathematically auditable by anyone.

Cuban's roleCo-founder and principal funder; the consumer price is the product.

Structural?Yes — a page template that binds the company on every product page.

Price-setterEngineered mechanism

2023 · Team Cuban Card

The template, re-used

The card programme republishes the same construction with a different schedule: the drug cost, a 15 per cent markup, a $12.00 fee and $1.00 — a published stack rather than a negotiated one. It is the first evidence that the Cost Plus page is a repeatable template rather than one product team's habit.

It also contains the clearest evidence that the transparency is a product decision rather than a corporate rule. The card's terms, dated 14 April 2023, put arbitration costs on “the claimant who initiates” — the inverse of the fee-advancement term in Cost Plus Drugs' own contract. Two affiliated entities drafted opposite terms within about eighteen months. Dispute clauses here look like counsel defaults, not founder policy.

Cuban's roleCo-founder; same corporate family.

Structural?Yes on price. No on contract — and the sibling inconsistency is itself a finding.

Price-setterIn-family repeat

2024–26 · Cost Plus Wellness

62 contracts at a zero fee

A public repository of direct employer–provider contracts, described by Cuban as “an open-source project, not a business”. The first contract is dated 22 November 2024; the public platform opened in January 2026; as of 6 September 2026 it publishes 62 provider contracts with no platform fee, no spread pricing, no shared-savings fee and no hidden administrative fee.

This is the strongest post-2022 parallel outside the pharmacy, and it is the one with the least to gain: there is no margin to align, because there is no margin. It is also, for that reason, untested by profit pressure — the FAQ notes “we may at some point charge for our services”.

Cuban's roleFounder and sponsor. Publishes the price; takes none of it.

Structural?Yes — and inside the same healthcare family as the other two.

Price-setterZero margin

Why this stops short of the strongest band. The price-setter thesis reaches SUPPORTS, not STRONGLY SUPPORTS, for four reasons the investigation states plainly: no Cost Plus inverse mechanism has a Strong pre-2022 operating analogue; the strongest replications are all inside one corporate family; HDNet supplies an eighteen-year counter-record; and important fee, contract, resale and support layers remained conventional even where the ticket or drug price was aligned.

The distinction that matters most

Practice is not architecture.

The Mavericks evidence and the Cost Plus evidence are both real. They are not the same kind of thing, and treating them as one continuous story is the single most common error made about Mark Cuban.

2006–2023 · Dallas Mavericks

Customer-aligned pricing

Practice

Owner-controlled — a decision, renewed each season
Repeatable while Cuban was in charge
Dependent on management choice, not on any document
Never written into a contract, a term or a published rule
Easier to reverse once control changed hands
Silent on the fee, resale and contract layer, which stayed at the league and vendor standard throughout

2022–2026 · Cost Plus family

Customer-aligned pricing

Architecture

Embedded in the product page itself
Fixed, published fee schedules
Mathematically auditable by any customer
Binding on every product page, not on a person's judgment
Capable of surviving founder discretion
Still silent on the contract layer — arbitration with no opt-out, a comparator anchored to a frozen benchmark

Instinct → Operating practice → Engineered mechanism

This is an evolution, not a continuity. The earlier practices were weaker analogues of the later mechanism, not early versions of it. The Mavericks never showed a fan “arena cost + team margin + ticketing fee” the way a Cost Plus page shows “manufacturing + 15% markup + pharmacy labour”. What travelled from one to the other was a disposition about price. What did not exist until 2022 was the machinery.

The natural experiment, handled carefully. Within fifteen months of Cuban's exit on 27 December 2023, the Mavericks' tenure-based loyalty pricing was discontinued and prices rose — using, in the team's own justification, the same market-referencing logic as Cuban's 2014 post, in the opposite direction. None of that is Cuban's conduct and none of it is debited to him. Its only evidential use is narrow: it shows the Cuban-era mechanisms were ownership choices rather than market outcomes, which supports the claim that he chose them — while confirming they were never made contractual.

The counter-record

Eighteen years on the other side of the line.

This is not a limitations note. The counter-record is the reason the broad founder thesis stays at WEAKLY SUPPORTS, and the strongest single item in it ran for longer than Cost Plus has existed.

6 Sep 2001 – 9 Sep 2019 · HDNet / AXS TV

The subscriber-invisible fee

HDNet was Cuban's principal media business and his longest-running one after the Mavericks. Its revenue was a per-subscriber carriage fee paid by distributors — “half of all revenues come from affiliate (carriage) fees paid by the Comcasts and DirecTVs”, as he wrote in May 2008. There was no HDNet subscription to compare, no HDNet price to cancel, and the rate was never disclosed in any source this investigation reached.

Four documented actions, all inside his control window, show him defending that invisibility:

16 April 2006 — writing to the FCC against mandated à la carte: “Its always a mistake to listen to your customers… You want ala carte, you got ala carte. Its called the internet.”
7 November 2007 — HDNet sued DirecTV to prevent its channels being moved out of the broad HD package into a $4.99 opt-in tier. The economic logic is the opposite of opt-in: the company wanted to be paid by all HD subscribers rather than only by those who chose it. The outcome of the suit was never located.
20 March 2009 — describing rising per-subscriber fees as the model's strength: “Not only are they going up, they are consistent.”
2006–2015 — sustained opposition to network-neutrality rules while a fee recipient inside the pipe.

Cuban's roleCo-founder and primary owner — but a supplier to the consumer's pricing surface, never its author.

Upstream18 years, in-windowPrimary source

What HDNet does and does not prove

The narrow point

HDNet is not evidence that Cuban was hostile to customers, and CHI does not present it that way. Two mitigations are on the record and both are real. He never claimed the bundle was a pro-consumer device; his argument was that it funds content, and he was candid about the economics. And within the bundle, the choices he did control ran the aligned way — HDNet Fights carried no pay-per-view surcharge (“While everyone else wants to make you pay extra on PPV for their fights. All of ours are free”, May 2009), and he spent years attacking rival channels that called themselves HD while delivering little of it.

The point is narrower, and it is the whole reason HDNet matters here:

When Cuban was upstream of the consumer price, he was willing to operate within an opaque bundled channel rather than reconstruct it around consumer transparency — and to litigate and lobby to keep it that way.The finding, stated at its actual width

The arguments he made for the bundle — that unbundling raises unit prices and starves investment — are structurally the same arguments the pharmacy benefit managers he now campaigns against make for rebate-funded pricing.

Role-dependentNot “hostile”

31 May 2006 – · Sharesleuth

Disclosure offered as the whole answer

Sharesleuth was a free, ad-free investigative site funded by the owner's short positions in the companies it investigated. Cuban announced the model himself: “This site is for the profit of its owners and we will buy and sell stocks that are discussed, before they are made available on the site… A journalistic conflict you say? Not any more. Not in this world. It will be fully disclosed and explained.”

Be precise about what was and was not disclosed. The disclosure existed and went beyond the industry norm of the time. What it disclosed was the existence of a position — not its size, entry or exit. When The Motley Fool asked for the trade data in 2008, the request went unanswered. The informational asymmetry that made the model profitable therefore remained after the disclosure was made.

CHI records this as a criticism of disclosure incompleteness. It is not characterised as market manipulation, and the site is dormant rather than closed — its last article is dated 17 November 2023.

UpstreamDisclosure as licence

27 Oct 2021 · Voyager promotion

Twelve weeks before Cost Plus

A Cuban-controlled company — the Mavericks — made Voyager Digital its “official cryptocurrency brokerage” and ran a fan promotion offering $100 in crypto to fans who deposited $100 and made a trade. Cuban appeared personally and, as quoted in the subsequent complaint and by Fortune on 11 August 2022, called the pricing “actually really good” and the product “as close to risk-free as you're gonna get”.

Cuban did not control Voyager. The significance here is endorsement and influence, not operating control, and the securities allegations were never adjudicated: Voyager filed for Chapter 11 in July 2022, the class action was dismissed on personal jurisdiction on 30 December 2025 without prejudice, reconsideration was denied on 27 May 2026, and an Eleventh Circuit appeal noticed in June 2026 remains pending. No court has ruled on whether the promotion was misleading.

What is not in dispute is the mechanism: a fan relationship channelled customers toward a third-party financial product using an inducement, a “commission-free” claim and a founder endorsement, with the counterparty's economics invisible to the fan. A materially less legible consumer proposition, carried by the same voice, weeks before the launch of a business whose entire proposition is that the price must be legible before trust is asked for.

Cuban's roleEndorser and controller of the channel — not of the price.

EndorserFiled claim, never adjudicated

Two more, inside the aligned businesses. In August 2022, under Cuban's ownership, a Mavericks ten-game mini-plan substituted a preseason game for a regular-season one, with the remedy — call your representative — arriving after a complaint went viral. And inside the Cost Plus family itself, the business-facing Marketplace launched in February 2024 with prices behind a registration wall: price-before-identity, inverted, by the same company, on a different customer.

Two tracks, one career

Alignment and contradiction coexist across time.

Neither track is a phase the other replaced. Read down a column: in almost every period, Cuban is doing both things at once, in different businesses, in different roles.

Period

2005–06

2007–10

2014–15

2021

2022–23

2024–26

Aligned price-setting

2006

Upper-bowl price cut and the $2 ticket. Finals auction declined in writing.

2010

Published floor: $2 / $5 / $10 tiers; more than 4,000 tickets under $20 for every game.

Feb 2014

Analyst-driven repricing process: price to fill the arena, not to maximise revenue. Direction of the reprice not stated.

—

No aligned price-setting exhibit in this window.

2022 · 2023

Cost Plus Drugs itemised page. Team Cuban Card republishes the stack.

2024–26

Cost Plus Wellness: 62 employer–provider contracts published at a zero platform fee.

Upstream / channel behaviour

Apr · May 2006

To the FCC against mandated à la carte. Sharesleuth launches on short-then-publish.

2007 · 2009

HDNet sues DirecTV to stay out of a $4.99 opt-in tier. Rising per-subscriber fees praised as the model's strength.

2014–15

Sustained opposition to network-neutrality rules while a fee recipient inside the pipe.

Oct 2021

Voyager promotion: fan-channel inducement and a personal endorsement of a “commission-free” proposition.

Aug 2022

Mavericks mini-plan substitutes a preseason game into a paid plan; remedy after a viral complaint.

2024–26

Marketplace prices behind a registration wall. Cost Plus's staffed phone line disclosed only in complaint responses.

Where he stood

Mavericks owner · HDNet owner · 2929 / Landmark / Magnolia

Mavericks owner · HDNet owner · Sharesleuth

Mavericks owner · AXS TV · Shark Tank investor · Cyber Dust

Mavericks owner · Fireside · twelve weeks before Cost Plus

Mavericks owner to 27 Dec 2023 · Cost Plus Drugs

Cost Plus family only. The Mavericks are no longer his.

Scroll the table horizontally →

What actually travels

The Cost Plus mechanisms have no ancestors.

CHI's Cost Plus assessment identified ten mechanisms that invert a standard industry hostility. This investigation tested each one against every business Cuban controlled before January 2022. This is the table the broad verdict turns on.

No Strong pre-2022 operating analogue exists for any Cost Plus inverse mechanism. Six have Weak analogues — all of them either the Mavericks' floor-tier ticketing or a free product. Two have documented anti-analogues in businesses Cuban controlled. The Strong replications appear only inside the healthcare family, and only after 2022. Four research streams working different material reached this negative independently.

Cost Plus mechanism	Pre-2022 analogue	Strength	Business	Post-2022 replication
Itemized Margin Disclosure Cost + 15% + fees on a public page	None. The nearest cousin is Sharesleuth's editor's note — the one earlier instance of Cuban telling a consumer his own economic interest. It disclosed existence, not amount.	None Weak cousin	Sharesleuth (2006–)	Strong Team Cuban Card republishes the stack; Wellness publishes contracts at zero margin.
Price-Before-Identity Price visible with no account	Mavericks box-office singles at published floor prices, sold without negotiation.	Weak	Mavericks (2010)	Strong Wellness contracts download without registration. Inverted in-family: Marketplace prices sit behind a login.
Catalog-First Workflow Check availability before recruiting the gatekeeper	None, unless the 2014 secondary-market monitoring is read as “see the market, then price” — a pricing input, not a customer workflow.	None	—	Weak Wellness lets an employer see providers and rates before engaging an administrator.
Single-Price Rule No coupons; one price for all	Mavericks floor tiers; HDNet Fights carried on the tier rather than pay-per-view. Applies to the cheapest inventory only — premium seats were variably priced, and Ultra VOD deliberately created a second, higher price for early access.	Weak	Mavericks; HDNet (2006–10)	Weak The card is a second single price under one brand. Strong on the supplier side.
Insured-Price Floor Insured member never pays more than cash	None. The mechanism is an artefact of third-party-payer pricing; no earlier Cuban business had a payer whose price could exceed cash.	None	—	Cousin Wellness bars balance billing above the contract rate.
Opt-In Recurrence Auto-refill opt-in, with notice	None — and a documented anti-analogue: HDNet sued in 2007 to prevent opt-in tiering of its own channel. The 2022 mini-plan substitution runs the same way.	Anti-analogue	HDNet (2007); Mavericks (2022)	Not established elsewhere.
Cadence-Neutral Fees Fees that do not punish quantity or cadence	Mavericks processing fees described as deliberately minimal, and the lowest primary-market fee load in the league — but contract-set with the ticketing vendor, and never itemised to the fan.	Weak	Mavericks (2017–24)	Strong The card fee is charged per fill regardless of days supplied.
Zero-Cost Exit No membership, no exit penalty	Cyber Dust was free and ephemeral by design; MicroSolutions had a refund guarantee on Cuban's own retrospective account. Contradicted by the courtside playoff resale ban — “you sell those tickets, you lose 'em”.	Weak Contradicted	Dust; Mavericks	Not established elsewhere.
Tracker Minimalism Analytics only; no ad pixels	Rhetoric only, then contradicted: Cyber Dust's 2014 claim that there were “no server logs. None” is contradicted by the company's own 2019 privacy policy.	Rhetoric only	Cyber Dust / Dust	Not established elsewhere.
Small-Claim Fee Advancement Company advances arbitration fees	None — and contradicted by a sibling. The Team Cuban Card's own terms put arbitration costs on the claimant.	None Sibling inverts it	Cost Plus Benefits (2023)	Supplier side Wellness plans pay providers in full within 30 days; patients are not billed.

The frictions have stronger ancestors than the mechanisms. The same table run against Cost Plus's frictions produces the opposite result. Form-only support with no published telephone recurs across Dust, the Team Cuban Card, the Marketplace and the pharmacy. A promotional promise that outruns the enforceable document recurs at Dust, at Fireside and at Cost Plus. In the words of the research: the low-touch trade is the constant; the price transparency is the variable.

Temporal evolution

The instinct is old. The machinery is new.

Customer-aligned pricing instincts appear early in Cuban's record. Engineered non-hostility emerges late. Nothing resembling the Cost Plus mechanisms existed in 2000, or in 2010.

1983–1999

Channel capture

MicroSolutions was itself the intermediary. Broadcast.com became an exclusive-licence aggregator that sold the audience to advertisers and corporate clients. Consumer alignment appears as a free product funded by someone else. There was no consumer price to make transparent.

2000–2011

Owner of the pipe

The strongest pre-2022 support and the strongest contradiction occur in the same years, from the same author, in different businesses: the Mavericks price floor alongside the HDNet bundle defence. The reconciling variable is whether Cuban set the consumer price.

2012–2019

Statements of the rule

“Making the most money possible is not a driving motivation” (2013). The analyst-driven pricing process (2014). Cyber Dust and its absolute privacy claims. Fifteen seasons of Shark Tank producing an investor-protection framework, not a customer-protection one. No consumer-facing transparency claim about his own businesses appears in this era.

2020–2021

The pivot year

The twelve months before Cost Plus, and the period in which his promotional voice is least calibrated to the mechanisms he endorsed: Fireside's terms against its stage rhetoric, the stated intention to begin capturing ticket resale, and the Voyager promotion in October 2021.

2022–2026

Transparency as the product

Cost Plus Drugs, the Team Cuban Card, the Marketplace, the Wellness contract repository, the Senate testimony. Every specific operating principle Cost Plus is praised for is first articulated here. The Mavericks sale in December 2023 removes the one long-running consumer business from his control.

The honest formulation. Cuban's transparency principle became an operating principle at the point where transparency became the product he was selling. That is a legitimate finding and it is not manufactured continuity — but it means the record is a late-emerging operating philosophy with a real prehistory as a pricing instinct, and a much longer prehistory as rhetoric aimed at other people's businesses.

The most repeatable trait

Low-touch digital support — and who answers when it fails.

The most repeatable operating trait in Cuban's post-2014 record is not the price architecture. It is a service architecture. And it is a friction, not an alignment.

DustWeb form only. No published telephone, no support email address.

Team Cuban CardEmail only.

Cost Plus MarketplaceA sales address only, behind a registration wall.

Cost Plus DrugsA web form and an assistant that cannot change an order; a staffed line that is not published.

The recurring architecture is forms, email, limited frontline human visibility, and founder accessibility operating outside the formal service channel. It appears in every Cuban-built digital product this investigation reached, regardless of whether the product is low-cost.

That last clause matters, because it kills a tidier story. CHI tested the proposition that Cuban trades lower extraction for higher friction as a recurring principle, and the research rejected it. MicroSolutions was high-touch by design. The Mavericks ran staffed ticket operations with the owner's email address on public display. Landmark moved deliberately toward reserved seating, lounges and recliners. The friction is not the price of the low price. It is how he builds software.

Founder accessibility

Real, long-running and personal: fan email answered from 2004 onward, a published address, hundreds of emails a day handled without an assistant, and the cold email from a doctor that became Cost Plus itself. It is discretionary, it depends on one person's attention, and it sits outside the company.

Structural support design

A system that prevents customers from needing founder intervention in the first place. This investigation found no documented case, in 2022–26, of Cuban personally resolving a Cost Plus order, restoring a prescription or answering a patient's product request. One publicly reported drug request went unanswered.

The distinction, stated plainly. Cuban answering emails personally is not the same thing as building a support system that prevents customers from needing founder intervention. The first is a personal habit with a real history. The second is a design question, and on the digital products the answer is consistently the same: the customer gets a form.

A correction CHI is making to its own earlier finding

Unpublished phone support — not absent phone support.

CHI's Cost Plus assessment described the company as having no patient-facing telephone number. This investigation found something narrower, more specific and more interesting, and the finding supersedes the earlier wording.

The normal Cost Plus consumer site does not publish a general patient-support telephone number.
The FAQ tells a customer who wants to cancel an order to “call right away” — without displaying a number to call.
The consumer-facing chatbot cannot perform urgent order or prescription-change functions.
Cost Plus's own responses to complaints on the Better Business Bureau, dated across 2024–25, cite a staffed customer-support telephone line with weekday operating hours.
The BBB business profile lists a telephone number.
The record does not establish that the BBB-listed number is necessarily the same line referenced in every company reply.
The live line was not tested.

The publishable finding. Cost Plus does have staffed phone support. It simply does not publish that channel on the normal consumer surface. The company has disclosed a support line reactively, in complaint responses, while the website continues to route ordinary patients through forms and automated assistance. CHI therefore classifies the mechanism as unpublished phone support, not absent phone support.

And the limit on the interpretation. CHI does not claim motive. It does not say the number is deliberately hidden, or that support is intentionally rationed. What it says is this: whatever the intention, keeping a staffed channel off the normal consumer surface functions as a support-rationing mechanism. A human channel exists; access to it is not made equally visible to the ordinary customer. This is recorded as a candidate pattern only — it is documented at one company, and CHI does not add a Lexicon term on a single instance.

Methodology

What this investigation changes about how CHI reads founders.

Founder-investigation rule

Ask who set the consumer price.

A founder-level assessment must not attribute customer-facing pricing behaviour to a founder merely because the founder was involved with the business. Involvement is not authorship. Before assessing a founder's customer-alignment record, establish which of these positions they actually occupied in the transaction the customer experienced.

OwnerHolds the equity

OperatorRuns the business

SupplierSells into someone else's price

InvestorFunds, does not decide

EndorserLends credibility

AdvocateArgues a position

Price setterDecides what the customer pays

Those roles produce different levels of attributable customer behaviour, and the Cuban record changes materially depending on which one he occupied. He owned HDNet outright for eighteen years and never set the price its viewers paid. He held no control over Voyager and lent it his voice. He owned the Mavericks and set the ticket floor himself. Read without the distinction, the record looks contradictory. Read with it, it resolves into a boundary.

CHI will carry this rule into future founder-level investigations. It is a methodological finding, not a Lexicon pattern, and no new Lexicon term is named on this record.

Evidence, verification and limits

Why the confidence is Medium, and what would move it.

Not because the major exhibits are weak. The strongest positive and negative exhibits are primary documents, dated, and re-verified in an independent audit pass.

What holds the verdict up

The exhibits that decide the band are primary

The Cost Plus product template and terms; the Team Cuban Card page and terms; the Wellness contract repository.
Cuban's own dated posts of 2006, 2010, 2013 and 2014 on Mavericks pricing.
Cuban's own dated posts of 2006, 2008 and 2009 on the bundle and carriage fees.
The Sharesleuth launch post; the Dust terms and privacy policy.
Both adversarial passes — one arguing for the thesis, one against — converged on the same boundary and the same post-2022 pattern. They disagreed about the band, not the facts.
Four research streams working different material reached the “no pre-2022 analogue” negative independently.

Why it is not higher

Bounded research, uneven attribution

Several “no analogue” findings are search-limited: the shared web-search budget was exhausted early in most streams, and much of the work proceeded by direct fetch of known documents. Positive findings are as strong as the document; negative findings are bounded by what could be reached.
The investigation spans businesses with materially different control structures and customer surfaces, and founder attribution is uneven across them.
Three of the heaviest exhibits rest on journalism rather than primary text: the Voyager press-conference quotations, the Mavericks loyalty-pricing programme, and the ticket fee-load figure.
The direction of the 2014 repricing — the single most important Mavericks process text — is not stated, so it carries as process only.
Litigation negatives for Landmark, Magnolia, HDNet and Broadcast.com are low-confidence: those dockets were essentially unsearched.

A finding that cuts both ways. No consumer-protection enforcement action against any Cuban-controlled company was located across roughly 25 years — no regulatory order, no state action, no adjudicated consumer class action. That is consistent with structural alignment. It is equally consistent with businesses niche or business-facing enough never to generate the volume of consumer harm that triggers enforcement. CHI does not conflate the two, and the negative is bounded by the search limits above.

Attribution discipline applied on this page

Every exhibit is placed against Cuban's control window and labelled by role. Nothing after 27 December 2023 at the Dallas Mavericks is treated as Cuban conduct — not the later pricing decisions, not the loyalty-pricing changes, not the broadcast arrangements executed by his successors. Statements are treated as claims to test, not as evidence. Quotations are used only where the research verified the wording and the date. Allegations that were never adjudicated are described as filed claims and not as findings. Where the research explicitly refuted a widely circulated premise, that premise does not appear here.

What would raise or lower the confidence

Raising it: archived Cuban-era Mavericks ticket terms, fee display and resale rules; a sample of the founder's replies to Cost Plus patients in 2024–26; the Voyager press-conference transcript; and the Cost Plus Marketplace economics behind its registration wall. Lowering it: a Cuban-era Mavericks document showing resale floors, transfer limits or dynamic pricing disclosed against the fan, or evidence that Cost Plus earns a per-claim spread in its benefit channel.

How the two verdicts relate

They answer different propositions. The broad thesis asks about the whole of Cuban's controlling and influencing record; on that record the supporting instances do not outweigh the eighteen-year counter-record enough to reach SUPPORTS, while the post-2022 pattern is too coherent and too structural to be dismissed. The narrower price-setter thesis asks only about the cases where Cuban set the consumer price; on that question the evidence is dated, primary where it matters, structural at least four times before Cost Plus and twice after, and confirmed in the negative by what happened once he no longer controlled the price. CHI publishes both bands rather than averaging them into one.

Final interpretation

A bounded, late-emerging example.

When Cuban sets the consumer price, the customer usually benefits. When he sits upstream of it, he is far more willing to use the same opaque channels he criticises elsewhere.

Mark Cuban is not a repeatable founder-level example of engineered non-hostility across his full business history. Nor is he a conventional operator whose one good business was an accident. He is a bounded example: the strongest recurring customer-alignment pattern appears where he directly controls the consumer price, and the strongest engineered version of that pattern appears only from 2022 onward, inside one corporate family, in one industry.

Cost Plus Drugs was not a one-off — the same founder re-used its template twice and testified to the mechanism under oath. But it was not proof of a lifelong consumer-first operating system either. The specific machinery it is praised for has no operating precedent in any business Cuban controlled before January 2022, and its structural opposite ran for eighteen years at HDNet.

The useful conclusion for a reader is not a verdict on a person. It is a question to carry into the next assessment of any founder, Cuban included: who set the price the customer paid? The record on either side of that line looks like two different people. It is one.

Continue

Related CHI work

Company assessmentCost Plus Drugs The investigation that triggered this one. A declared consumer champion, audited adversarially. Verdict: supports. How CHI worksMethodology Scoring, evidence grading, control classes and the disciplines this page applies. IndexSpecial Investigations CHI's deeper research projects, including the Elon Musk founder-level investigation. LexiconPromise Reversal & Exit Resistance The two existing CHI patterns this record touches most often. No new term is named here.